| |
| |
|
| Insider
Information: |
Sandman Paul W |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
329,646 |
|
|
Indirect Shares
|
2,900 |
|
|
| Direct
Value |
$5,700,668 |
|
|
|
Indirect Value
|
$219,153 |
|
|
| Total
Shares |
332,546 |
|
|
| Total
Value |
$5,919,821 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
EVP and General Counsel |
2008-02-29 |
66,846 |
2008-02-29 |
2,900 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2018-06-08 |
262,800 |
2009-04-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
29 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2015-05-28 |
4 |
A |
$6.80 |
$150,001 |
D/D |
22,059 |
76,700 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2016-06-02 |
4 |
A |
$3.52 |
$250,001 |
D/D |
71,023 |
147,723 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2017-06-09 |
4 |
A |
$2.47 |
$150,001 |
D/D |
60,729 |
208,452 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2018-06-08 |
4 |
A |
$2.76 |
$150,000 |
D/D |
54,348 |
262,800 |
0 |
- |
|
29 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
